Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathy
Authors
Bruce A. Perkins (ORCID: https://orcid.org/0000-0002-5885-0046)
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathy
Bruce A. Perkins, Natalia McInnes, Zubin Punthakee, Paul Fernyhough et al.
Journal
EBioMedicine
Topics
Pain Mechanisms and Treatments
article
Topical application of the antimuscarinic pirenzepine increased lower limb nerve fibre density in a phase 2a study in type 2 patients with diabetes with peripheral neuropathy
Bruce A. Perkins, Natalia McInnes, Zubin Punthakee, Paul Fernyhough, Nigel A. Calcutt, Kimberly Gardner, Douglas W. Zochodne, Ajith Sivadasan, Sylvie Gosselin, Ari Breiner, Vera Bril, Katie E. Frizzi, Angela Hansen
article en
Abstract
No abstract available for this paper.
Publication Tag
EBioMedicineVol. 123
Institutions
Mount Sinai Hospital (CA), University Health Network (CA), University of Toronto (CA), Foreign Trade University (VN), St. Boniface Hospital (CA), Ottawa Hospital (CA), Centre Hospitalier Universitaire de Sherbrooke (CA), Toronto General Hospital (CA), University of California San Diego (US), Sinai Health System (CA), Women and Children’s Health Research Institute (CA), Ottawa Hospital Research Institute (CA), McMaster University (CA)
Funders
Research Manitoba, Canadian Institutes of Health Research